Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study.

Tufail, Adnan; J Patel, Praveen; Egan, Catherine; Hykin, Philip; da Cruz, Lyndon; Gregor, Zdenek; Dowler, Jonathan; A Majid, Mohammed; Bailey, Clare; Mohamed, Quresh; Johnston, Robert; Bunce, Catey; Xing, Wen; Trial Investigators, ABC

doi:10.1136/bmj.c2459

Public

Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study.

Published in BMJ (Clinical research ed.) • Jun 9, 2010

NobleIDark:/48914/w1/20260526/10751E8FRecord on NobleID

Authors:

Adnan Tufail

,

Praveen J Patel

,

Catherine Egan

Abstract

OBJECTIVES: To evaluate the efficacy and safety of intravitreous bevacizumab injections for the treatment of neovascular age related macular degeneration. DESIGN: Prospective, double masked, multicentre, randomised controlled trial. SETTING: Three ophthalmology centres in the United Kingdom. PARTICI...

Discussions